These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 28406092

  • 21. 6-Mercaptopurine for Azathioprine Intolerant Inflammatory Bowel Disease: Literature Search and Reappraisal of Own Data.
    Actis GC, Pellicano R, Rosina F.
    Inflamm Allergy Drug Targets; 2015; 14(2):133-7. PubMed ID: 26728773
    [Abstract] [Full Text] [Related]

  • 22. Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience.
    Macaluso FS, Renna S, Maida M, Dimarco M, Sapienza C, Affronti M, Orlando E, Rizzuto G, Orlando R, Ventimiglia M, Cottone M, Orlando A.
    Scand J Gastroenterol; 2017 Sep; 52(9):981-987. PubMed ID: 28554266
    [Abstract] [Full Text] [Related]

  • 23. Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
    López-Martín C, Chaparro M, Espinosa L, Bejerano A, Maté J, Gisbert JP.
    Gastroenterol Hepatol; 2011 Sep; 34(6):385-92. PubMed ID: 21616565
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease.
    Bermejo F, López-Sanromán A, Algaba A, Van-Domselaar M, Gisbert JP, García-Garzón S, Garrido E, Piqueras B, De La Poza G, Guerra I.
    Aliment Pharmacol Ther; 2010 Jan; 31(1):120-4. PubMed ID: 19709096
    [Abstract] [Full Text] [Related]

  • 27. Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease.
    Grosen A, Nersting J, Bungum M, Christensen LA, Schmiegelow K, Spanò M, Julsgaard M, Cordelli E, Leter G, Larsen PB, Hvas CL, Kelsen J.
    J Crohns Colitis; 2019 Jan 01; 13(1):3-11. PubMed ID: 29917107
    [Abstract] [Full Text] [Related]

  • 28. Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease.
    Lucas Ramos J, Suárez Ferrer C, Poza Cordón J, Sánchez Azofra M, Rueda García JL, Martin Arranz E, Yebra Carmona J, Andaluz García I, Martín Arranz MD.
    Gastroenterol Hepatol; 2021 May 01; 44(5):337-345. PubMed ID: 33272733
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
    Soh JS, Yun WJ, Kim KJ, Won CH, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Kim JH.
    Inflamm Bowel Dis; 2015 Apr 01; 21(4):832-9. PubMed ID: 25789922
    [Abstract] [Full Text] [Related]

  • 31. Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.
    Ansari A, Elliott T, Baburajan B, Mayhead P, O'Donohue J, Chocair P, Sanderson J, Duley J.
    Aliment Pharmacol Ther; 2008 Sep 15; 28(6):734-41. PubMed ID: 19145729
    [Abstract] [Full Text] [Related]

  • 32. Relationship between azathioprine dosage and thiopurine metabolites in pediatric IBD patients: identification of covariables using multilevel analysis.
    Nguyen TV, Vu DH, Nguyen TM, Lachaux A, Boulieu R.
    Ther Drug Monit; 2013 Apr 15; 35(2):251-7. PubMed ID: 23503453
    [Abstract] [Full Text] [Related]

  • 33. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
    Barnes BH, Borowitz SM, Saulsbury FT, Hellems M, Sutphen JL.
    J Pediatr Gastroenterol Nutr; 2004 May 15; 38(5):509-12. PubMed ID: 15097439
    [Abstract] [Full Text] [Related]

  • 34. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis.
    Münch A, Fernandez-Banares F, Munck LK.
    Aliment Pharmacol Ther; 2013 Apr 15; 37(8):795-8. PubMed ID: 23432370
    [Abstract] [Full Text] [Related]

  • 35. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).
    Shim L, Eslick GD, Simring AA, Murray H, Weltman MD.
    J Crohns Colitis; 2011 Jun 15; 5(3):234-8. PubMed ID: 21575887
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, Loftus EV, Peyrin-Biroulet L, Blonski WC, Van Domselaar M, Chaparro M, Sandilya S, Bewtra M, Beigel F, Biancone L, Lichtenstein GR.
    Clin Gastroenterol Hepatol; 2015 May 15; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical predictors of thiopurine-related adverse events in Crohn's disease.
    Moran GW, Dubeau MF, Kaplan GG, Yang H, Eksteen B, Ghosh S, Panaccione R.
    World J Gastroenterol; 2015 Jul 07; 21(25):7795-804. PubMed ID: 26167079
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.